BRTX
BioRestorative Therapies, Inc.
NASDAQ · Healthcare · Biotechnology · US
$0.15
+2.99%Margins
Gross margin
92.1%
EBITDA margin
-3030.7%
EBIT margin
-3975.0%
Net margin
-3089.6%
FCF margin
-3324.6%
-365.4%
Return on equity
-238.3%
Return on assets
-464.9%
Return on invested capital
0.08x
Asset turnover
-$11.8M
Cash from operations
$0.13
Cash per share
Margins, returns on capital and operating efficiency from the latest trailing period · Data as of Mar 1, 2026